Terms ending in 2040
Every in-force patent on Pfizer Inc.'s record whose computed term ends in 2040, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,359,024 | ANTI-AVB8 Antibodies and Compositions and Uses Thereof In force · High confidence | The Regents of the University of California | In force | High confidence | |
| US 12,371,499 | Method of Treating Cancer Using ANTI-AVß8 Antibodies In force · High confidence | Pfizer Inc. and The Regents of the University of California | In force | High confidence | |
| US 11,350,520 | Component Carrier and Method of Manufacturing the Same In force · High confidence | Pfizer Limited | In force | High confidence | |
| US 11,014,911 | CDK2 Inhibitors In force · High confidence | Pfizer Inc. | In force | High confidence | |
| US 11,718,603 | CDK2 Inhibitors In force · High confidence | Pfizer Inc. | In force | High confidence | |
| US 11,566,006 | Solid State Forms of (S)-2-(((S)-6,8-Difluoro-1,2,3,4-Tetrahydronaphthalen-2-YL)AMINO)-N-(1-(2-Methyl-1-(NEOPENTYLAMINO)PROPAN-2-YL)-1H-IMIDAZOL-4-YL)PENTANAMIDE and Uses Thereof In force · High confidence | Pfizer Inc. | In force | High confidence | |
| US D1,060,387 | Display Screen or Portion Thereof with Graphical User Interface In force · High confidence | Pfizer Inc. | In force | High confidence | |
| US D1,063,100 | Diagnostic Device with LED Display In force · High confidence | Pfizer Inc. | In force | High confidence | |
| US 11,364,303 | Cysteine Engineered Antibody Drug Conjugates In force · Medium confidence | Pfizer Inc. | In force | Medium confidence | |
| US 11,958,901 | Nucleic acids encoding variable regions of anti-CXCR5 antibodies In force · High confidence | The Regents of the University of California | In force | High confidence | |
| 22 more term ends in 2040 · Pro | |||||
10 of 32 patents shown. Soonest term end first, then patent number.
Pro members see all 32.
28 of these are in force and held by Pfizer Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.